Brevan Howard Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.69M Buy
16,292
+12,767
+362% +$1.45M 0.01% 637
2025
Q4
$355K Buy
+3,525
New +$383K ﹤0.01% 1281
2025
Q3
Sell
-56,977
Closed -$6.84M 1977
2025
Q2
$6.84M Buy
56,977
+37,694
+195% +$5.03M 0.04% 264
2025
Q1
$2.84M Buy
+19,283
New +$2.94M 0.03% 234
2024
Q4
Sell
-19,469
Closed -$3.17M 1093
2024
Q3
$3.17M Buy
19,469
+11,196
+135% +$1.66M 0.02% 184
2024
Q2
$1.13M Buy
8,273
+3,522
+74% +$489K 0.01% 336
2024
Q1
$727K Buy
4,751
+813
+21% +$121K 0.01% 354
2023
Q4
$562K Buy
+3,938
New +$525K 0.01% 428

Other funds holding CLX

Brevan Howard Capital Management's CLX Position: Q1 2026 in Review

Brevan Howard Capital Management increased its Clorox (CLX) stake by 362% in Q1 2026, buying an estimated $1.45M and bringing the position to 16,292 shares worth $1.69M. The position accounts for 0.01% of the portfolio, ranked #637.

Brevan Howard Capital Management first reported a position in CLX in Q4 2023 and has held it in 8 quarters since. The position peaked at $6.84M in Q2 2025. 1,080 funds tracked by Wall St. Rank hold CLX as of Q1 2026.

  • Brevan Howard Capital Management held 16,292 shares of Clorox worth $1.69M as of Q1 2026.
  • Brevan Howard Capital Management bought 12,767 Clorox shares in Q1 2026, an estimated $1.45M.
  • Clorox made up 0.01% of Brevan Howard Capital Management's portfolio in Q1 2026, its #637 holding.
  • Brevan Howard Capital Management first reported a position in Clorox in Q4 2023 and has held it in 8 quarters since.
  • Brevan Howard Capital Management's Clorox position peaked at $6.84M in Q2 2025.
  • 1,080 funds tracked by Wall St. Rank held Clorox as of Q1 2026.

Based on Brevan Howard Capital Management's 13F filing for Q1 2026, filed 15 May 2026.